These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 479379)

  • 1. The one-point method in predicting dosage regimen in case of hepatic and/or renal failure in presence or absence of change in volume of distribution.
    Ritschel WA; Thompson GA
    J Clin Pharmacol; 1979 Jul; 19(7):350-6. PubMed ID: 479379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal failure, drug pharmacokinetics and drug action.
    Fabre J; Balant L
    Clin Pharmacokinet; 1976; 1(2):99-120. PubMed ID: 13956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The repeated one-point method for predicting dose sizes with irregular dosing intervals.
    Thompson GA; Ritschel WA
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):337-43. PubMed ID: 3733283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic comparison of the one-point method with other methods in predicting steady state drug concentrations in multiple dosing.
    Ritschel WA; Erni W
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):279-87. PubMed ID: 881281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug dosage in patients with renal disease.
    Dettli LC
    Clin Pharmacol Ther; 1974 Jul; 16(1):274-80. PubMed ID: 4843318
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disopyramide kinetics in renal impairment: determinants of interindividual variability.
    Burk M; Peters U
    Clin Pharmacol Ther; 1983 Sep; 34(3):331-40. PubMed ID: 6883909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of host factors on drug response. VII. Renal diseases.
    Vesell ES
    Ration Drug Ther; 1981 Nov; 15(11):1-9. PubMed ID: 7345476
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of hepatic and renal disorders on the pharmacokinetics of sulfachloropyridacine.
    Mariño EL; Dominguez-Gil A; Tabernero JM; Macias JG
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):10-4. PubMed ID: 7364528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
    Turnheim K
    Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of drug dosage regimens in patients with renal disease: a new nomographic method.
    Spring P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):76-80. PubMed ID: 1150365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy reviews: clinical pharmacology of antiepileptic drugs.
    Browne TR
    Am J Hosp Pharm; 1978 Sep; 35(9):1048-56. PubMed ID: 358830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose size and dosing interval determination.
    Ritschel WA
    Arzneimittelforschung; 1975 Sep; 25(9):1442-7. PubMed ID: 1242670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-dose and multiple-dose kinetics of minocycline in patients with renal disease.
    Sklenar I; Spring P; Dettli L
    Agents Actions; 1977 Sep; 7(3):369-77. PubMed ID: 596320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.